Home
Civitas Therapeutics

Civitas Therapeutics Market Share Analysis for July 2026

Civitas Therapeutics is developing breakthrough therapies in Parkinson's disease and research.

Industry: N/A

Domaincivitastherapeutics.com

Year Founded2009

Employees501 - 1000

Annual Revenue$25M - $50M

Civitas Therapeutics

Civitas Therapeutics (including company regionals)

civitastherapeutics.com

See more website traffic and engagement information

Civitas Therapeutics Revenue up to July 2026 is 25M - 50M

revenue generated by Civitas Therapeutics top domains

Civitas Therapeutics top domains revenue over 3 years

Revenue for Civitas Therapeutics top domains

civitastherapeutics.com25M - 50M

See more with Sales Intelligence

Total visits to Civitas Therapeutics's top domains

Understand Civitas Therapeutics market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Civitas Therapeutics's top domains

Analyze Civitas Therapeutics engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Civitas Therapeutics's top domains

See how Civitas Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Civitas Therapeutics top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Civitas Therapeutics

These are the website technologies, by industry, used by Civitas Therapeutics top domains

Conversion & Analytics (1)

Google Analytics

News & Signals from Civitas Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAcorda acquired Civitastherapeutics for $121M on Jan 1st '14.Acorda acquired Inbrija in the acquisition of Civitas Therapeutics.